Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Opal

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Chest|June 19, 1998
The uncertain value of the definition for SIRS. Systemic inflammatory response syndromeS M Opal
Current Opinion in Critical Care|January 24, 2002
Clinical impact of novel anticoagulation strategies in sepsisS M Opal
Critical Care Medicine|June 2, 2000
Hemofiltration-absorption systems for the treatment of experimental sepsis: is it possible to remove the "evil humors" responsible for septic shock?S M Opal
Critical Care Medicine|September 28, 2000
Phylogenetic and functional relationships between coagulation and the innate immune responseS M Opal
Critical Care Medicine|March 13, 1999
Tumor necrosis factor receptor expression on inflammatory cells in sepsisS M Opal
Medicine and Health, Rhode Island|March 1, 1996
Infectious disease challenges in the 1990'sS M Opal
Critical Care Medicine|September 28, 2000
Therapeutic rationale for antithrombin III in sepsisS M Opal
Critical Care Medicine|October 3, 1999
Selenium replacement in severe systemic inflammatory response syndromeS M Opal
Chest|September 14, 2001
Protein C levels in severe sepsisS M Opal
Critical Care Medicine|September 2, 1999
Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?S M Opal, J Cohen
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Chest|June 19, 1998
The uncertain value of the definition for SIRS. Systemic inflammatory response syndromeS M Opal
Current Opinion in Critical Care|January 24, 2002
Clinical impact of novel anticoagulation strategies in sepsisS M Opal
Critical Care Medicine|June 2, 2000
Hemofiltration-absorption systems for the treatment of experimental sepsis: is it possible to remove the "evil humors" responsible for septic shock?S M Opal
Critical Care Medicine|September 28, 2000
Phylogenetic and functional relationships between coagulation and the innate immune responseS M Opal
Critical Care Medicine|March 13, 1999
Tumor necrosis factor receptor expression on inflammatory cells in sepsisS M Opal
Medicine and Health, Rhode Island|March 1, 1996
Infectious disease challenges in the 1990'sS M Opal
Critical Care Medicine|September 28, 2000
Therapeutic rationale for antithrombin III in sepsisS M Opal
Critical Care Medicine|October 3, 1999
Selenium replacement in severe systemic inflammatory response syndromeS M Opal
Chest|September 14, 2001
Protein C levels in severe sepsisS M Opal
Critical Care Medicine|September 2, 1999
Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?S M Opal, J Cohen
Pageof 11